Log In
Print
BCIQ
Print
Print this Print this
 

Lymphomun (FBTA05)

Also known as: formerly TPBs05

  Manage Alerts
Collapse Summary General Information
Company Trion Pharma GmbH
DescriptionTrifunctional antibody against CD20 antigen
Molecular Target CD20
Mechanism of ActionBinds CD20; Binds CD3
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationB cell lymphoma
Indication DetailsTreat B cell lymphoma
Regulatory Designation

Partner

Fresenius SE & Co. KGaA


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today